479 related articles for article (PubMed ID: 31298377)
21. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
22. miR‑454‑3p inhibits non‑small cell lung cancer cell proliferation and metastasis by targeting TGFB2.
Liao H; Liang Y; Kang L; Xiao Y; Yu T; Wan R
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760169
[TBL] [Abstract][Full Text] [Related]
23. MiR-296-3p may affect the proliferation and migration of non-small cell lung cancer cells via regulating RABL3.
Ge T; Wu HC; Zhou YY; Shen SM; Zhu LG; You GX
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5823-5830. PubMed ID: 31298353
[TBL] [Abstract][Full Text] [Related]
24. MiR-504 inhibits cell proliferation and invasion by targeting LOXL2 in non small cell lung cancer.
Ye MF; Zhang JG; Guo TX; Pan XJ
Biomed Pharmacother; 2018 Jan; 97():1289-1295. PubMed ID: 29156517
[TBL] [Abstract][Full Text] [Related]
25. circMTDH.4/miR-630/AEG-1 axis participates in the regulation of proliferation, migration, invasion, chemoresistance, and radioresistance of NSCLC.
Li YH; Xu CL; He CJ; Pu HH; Liu JL; Wang Y
Mol Carcinog; 2020 Feb; 59(2):141-153. PubMed ID: 31749230
[TBL] [Abstract][Full Text] [Related]
26. miR-200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non-small cell lung cancer cells.
Tang Q; Li M; Chen L; Bi F; Xia H
Int J Oncol; 2018 Oct; 53(4):1732-1742. PubMed ID: 30066855
[TBL] [Abstract][Full Text] [Related]
27. MiR-1 targets PIK3CA and inhibits tumorigenic properties of A549 cells.
Yu QQ; Wu H; Huang X; Shen H; Shu YQ; Zhang B; Xiang CC; Yu SM; Guo RH; Chen L
Biomed Pharmacother; 2014 Mar; 68(2):155-61. PubMed ID: 24486107
[TBL] [Abstract][Full Text] [Related]
28. miR-138 suppresses the proliferation, metastasis and autophagy of non-small cell lung cancer by targeting Sirt1.
Ye Z; Fang B; Pan J; Zhang N; Huang J; Xie C; Lou T; Cao Z
Oncol Rep; 2017 Jun; 37(6):3244-3252. PubMed ID: 28498463
[TBL] [Abstract][Full Text] [Related]
29. Circ_0016760 accelerates non-small-cell lung cancer progression through miR-646/AKT3 signaling in vivo and in vitro.
Chen S; Zhou L; Ran R; Huang J; Zheng Y; Xing M; Cai Y
Thorac Cancer; 2021 Dec; 12(23):3223-3235. PubMed ID: 34658165
[TBL] [Abstract][Full Text] [Related]
30. Hsa_circ_0016760 exacerbates the malignant development of non‑small cell lung cancer by sponging miR‑145‑5p/FGF5.
Zhu Z; Wu Q; Zhang M; Tong J; Zhong B; Yuan K
Oncol Rep; 2021 Feb; 45(2):501-512. PubMed ID: 33416186
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of miR-758 inhibited proliferation, migration, invasion, and promoted apoptosis of non-small cell lung cancer cells by negatively regulating HMGB.
Zhou GH; Lu YY; Xie JL; Gao ZK; Wu XB; Yao WS; Gu WG
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30446524
[TBL] [Abstract][Full Text] [Related]
32. MiR-323-3p Targeting Transmembrane Protein with EGF-Like and 2 Follistatin Domain (TMEFF2) Inhibits Human Lung Cancer A549 Cell Apoptosis by Regulation of AKT and ERK Signaling Pathways.
Fan JM; Zheng ZR; Zeng YM; Chen XY
Med Sci Monit; 2020 Feb; 26():e919454. PubMed ID: 32009129
[TBL] [Abstract][Full Text] [Related]
33. Study on molecular mechanism of MiRNA-29a in promoting proliferation and invasion of non-small-cell lung cancer by inhibiting MTSS1.
Liu M; Zeng X; Lu YX; Mo YJ; Liao TH; Gan C; Lu XQ
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5531-5538. PubMed ID: 30229825
[TBL] [Abstract][Full Text] [Related]
34. Reduced miR-363-3p expression in non-small cell lung cancer is associated with gemcitabine resistance via targeting of CUL4A.
Bian WG; Zhou XN; Song S; Chen HT; Shen Y; Chen P
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):649-659. PubMed ID: 30720173
[TBL] [Abstract][Full Text] [Related]
35. MiR-124 changes the sensitivity of lung cancer cells to cisplatin through targeting STAT3.
Qi MM; Ge F; Chen XJ; Tang C; Ma J
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5242-5250. PubMed ID: 31298375
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-126 Targeting PIK3R2 Inhibits NSCLC A549 Cell Proliferation, Migration, and Invasion by Regulation of PTEN/PI3K/AKT Pathway.
Song L; Li D; Gu Y; Wen ZM; Jie J; Zhao D; Peng LP
Clin Lung Cancer; 2016 Sep; 17(5):e65-e75. PubMed ID: 27236384
[TBL] [Abstract][Full Text] [Related]
37. MiR-93-5p up-regulation is involved in non-small cell lung cancer cells proliferation and migration and poor prognosis.
Yang W; Bai J; Liu D; Wang S; Zhao N; Che R; Zhang H
Gene; 2018 Mar; 647():13-20. PubMed ID: 29309884
[TBL] [Abstract][Full Text] [Related]
38. Clinical Significance and Tumor-Suppressive Function of miR-516b in Nonsmall Cell Lung Cancer.
Zhu J; Zhang Y; Yang X; Jin L
Cancer Biother Radiopharm; 2017 May; 32(4):115-123. PubMed ID: 28514208
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-130a targeting hypoxia-inducible factor 1 alpha suppresses cell metastasis and Warburg effect of NSCLC cells under hypoxia.
Shi J; Wang H; Feng W; Huang S; An J; Qiu Y; Wu K
Life Sci; 2020 Aug; 255():117826. PubMed ID: 32450163
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
